
ViewRay VRAY
Quarterly report 2023-Q1
added 05-11-2023
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
181 M |
Market Cap[1] |
$ 468 M |
EBITDA (LTM) |
$ -102 M |
P/E (LTM) |
- |
P/S (LTM) |
6.19 |
EPS (LTM) |
-0.64 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 192.45 | 4.02 % | $ 14.4 B | Nasdaq Global Select Market,SPB | ||
|
Bruker Corporation
BRKR
|
$ 40.01 | 2.73 % | $ 5.96 K | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.69 | 0.87 % | $ 1.72 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.44 | -4.18 % | $ 129 M | Nasdaq Global Market | ||
|
Boston Scientific Corporation
BSX
|
$ 64.46 | 1.64 % | $ 95.4 B | NYSE,SPB | ||
|
Electromed
ELMD
|
$ 26.01 | 2.42 % | $ 220 M | NYSE American | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.62 | 0.82 % | $ 38.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.05 | 5.27 % | $ 313 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.82 | 1.72 % | $ 395 M | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
LENSAR
LNSR
|
$ 6.0 | 3.45 % | $ 71.7 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 95.22 | 2.65 % | $ 12.9 B | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.11 | 2.18 % | $ 1.28 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 5.53 | 4.44 % | $ 1.17 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Inogen
INGN
|
$ 6.88 | 4.4 % | $ 183 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.04 | 0.01 % | $ 17.6 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 10.88 | 0.46 % | $ 390 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 57.28 | 1.47 % | $ 1.68 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.14 | 3.24 % | $ 1.21 B | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 67.64 | 4.04 % | $ 3.69 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 90.69 | 2.63 % | $ 3.15 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.79 | 0.13 % | $ 123 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 81.08 | 2.57 % | $ 47.4 B | NYSE,SPB | ||
|
Penumbra
PEN
|
$ 332.68 | 0.37 % | $ 12.9 B | NYSE,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.